Editorial: the prevalence of Helicobacter pylori infection worldwide-knowns and unknowns. Authors' reply

M Zamani^{1

2}, M H Derakhshan³, V Zamani⁴, J Shokri-Shirvani⁵

Affiliations

¹ Student Research Committee, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
² Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
³ Faculty of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
⁴ Vice-Chancellery for Health, Babol University of Medical Sciences, Babol, Iran.
⁵ Department of Internal Medicine, Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.

Editorial

M Zamani et al. Aliment Pharmacol Ther. 2018 May.

. 2018 May;47(9):1331-1332.

doi: 10.1111/apt.14618.

M Zamani^{1

2}, M H Derakhshan³, V Zamani⁴, J Shokri-Shirvani⁵

¹ Student Research Committee, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
² Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
³ Faculty of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
⁴ Vice-Chancellery for Health, Babol University of Medical Sciences, Babol, Iran.
⁵ Department of Internal Medicine, Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.

No abstract available

Comment on

Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection.
Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, Derakhshan MH. Zamani M, et al. Aliment Pharmacol Ther. 2018 Apr;47(7):868-876. doi: 10.1111/apt.14561. Epub 2018 Feb 12. Aliment Pharmacol Ther. 2018. PMID: 29430669
Editorial: the prevalence of Helicobacter pylori infection worldwide-knowns and unknowns.
Tsipotis E, Leontiadis GI. Tsipotis E, et al. Aliment Pharmacol Ther. 2018 May;47(9):1330-1331. doi: 10.1111/apt.14609. Aliment Pharmacol Ther. 2018. PMID: 29644744 No abstract available.